Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories
出版年份 2019 全文链接
标题
Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories
作者
关键词
-
出版物
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 57, Issue 6, Pages -
出版商
American Society for Microbiology
发表日期
2019-04-05
DOI
10.1128/jcm.00203-19
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests
- (2018) Shelley A. Campeau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model
- (2018) James M. Kidd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 21st Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance
- (2018) Romney M Humphries et al. CLINICAL INFECTIOUS DISEASES
- Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials
- (2018) M. Tandan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls
- (2018) Romney M. Humphries et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
- (2018) Patrick N. A. Harris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, But Closer Attention from Regulatory Bodies is Needed.
- (2018) James A. McKinnell et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae
- (2016) Sarah M. Bartsch et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting
- (2016) B. J. Langford et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica
- (2015) Eszter Deak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical Outcomes of Enterobacteriaceae Infections Stratified by Carbapenem MICs
- (2014) Twisha S. Patel et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Performance of Etest and Disk Diffusion for Detection of Ciprofloxacin and Levofloxacin Resistance in Salmonella enterica
- (2014) Eszter Deak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae andPseudomonas aeruginosa:I. Cephalosporins and Aztreonam
- (2013) Michael N. Dudley et al. CLINICAL INFECTIOUS DISEASES
- A Current Perspective on Daptomycin for the Clinical Microbiologist
- (2013) R. M. Humphries et al. CLINICAL MICROBIOLOGY REVIEWS
- Cefazolin as a class representative for oral cephalosporins and uncomplicated urinary tract infections caused by indicated Enterobacteriaceae
- (2013) Audrey N. Schuetz et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In Vitro Susceptibility Testing of Fluoroquinolone Activity Against Salmonella: Recent Changes to CLSI Standards
- (2012) R. M. Humphries et al. CLINICAL INFECTIOUS DISEASES
- Putting the New CLSI Cephalosporin and Carbapenem Breakpoint Changes Into Practice in Clinical Microbiology Laboratories
- (2012) J. H. Jorgensen Journal of the Pediatric Infectious Diseases Society
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
- (2011) Kalpana Gupta et al. CLINICAL INFECTIOUS DISEASES
- Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance Breakpoint
- (2008) V. H. Tam et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started